These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 3539030)

  • 1. DDAVP and urine osmolality in refractory enuresis.
    Dimson SB
    Arch Dis Child; 1986 Nov; 61(11):1104-7. PubMed ID: 3539030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desmopressin for nocturnal enuresis: urinary osmolality and response.
    Folwell AJ; Macdiarmid SA; Crowder HJ; Lord AD; Arnold EP
    Br J Urol; 1997 Sep; 80(3):480-4. PubMed ID: 9313673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desmopressin in nocturnal enuresis.
    Aladjem M; Wohl R; Boichis H; Orda S; Lotan D; Freedman S
    Arch Dis Child; 1982 Feb; 57(2):137-40. PubMed ID: 7039520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of DDAVP is related to the circadian rhythm of urine output in patients with persisting nocturnal enuresis.
    Hunsballe JM; Hansen TK; Rittig S; Pedersen EB; Djurhuus JC
    Clin Endocrinol (Oxf); 1998 Dec; 49(6):793-801. PubMed ID: 10209568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of intranasal DDAVP therapy in children with nocturnal enuresis.
    Shu SG; Lii YP; Chi CS
    Zhonghua Yi Xue Za Zhi (Taipei); 1993 Dec; 52(6):368-71. PubMed ID: 8299037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to desmopressin as a function of urine osmolality in the treatment of monosymptomatic nocturnal enuresis: a double-blind prospective study.
    Rushton HG; Belman AB; Zaontz M; Skoog SJ; Sihelnik S
    J Urol; 1995 Aug; 154(2 Pt 2):749-53. PubMed ID: 7609170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daytime functional bladder capacity as a predictor of response to desmopressin in monosymptomatic nocturnal enuresis.
    Eller DA; Austin PF; Tanguay S; Homsy YL
    Eur Urol; 1998; 33 Suppl 3():25-9. PubMed ID: 9599733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desmopressin in the management of nocturnal enuresis in children: a double-blind study.
    Birkásová M; Birkás O; Flynn MJ; Cort JH
    Pediatrics; 1978 Dec; 62(6):970-4. PubMed ID: 366538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term home studies of water balance in patients with nocturnal enuresis.
    Rittig S; Schaumburg H; Schmidt F; Hunsballe JM; Hansen AF; Kirk J; Vestergaard P; Djurhuus JC
    Scand J Urol Nephrol Suppl; 1997; 183():25-6; discussion 26-7. PubMed ID: 9165600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DDAVP in young enuretic patients: a double-blind trial.
    Ferrie BG; MacFarlane J; Glen ES
    Br J Urol; 1984 Aug; 56(4):376-8. PubMed ID: 6398716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of oral desmopressin in the treatment of primary nocturnal enuresis in Asian children.
    Yap HK; Chao SM; Tan AY; Murugasu B; Ong EK; Low EH
    J Paediatr Child Health; 1998 Apr; 34(2):151-3. PubMed ID: 9588639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined therapy of enuresis alarm and desmopressin in the treatment of nocturnal enuresis.
    Sukhai RN; Mol J; Harris AS
    Eur J Pediatr; 1989 Feb; 148(5):465-7. PubMed ID: 2646131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desmopressin acetate and nocturnal enuresis: how much do we know?
    Moffatt ME; Harlos S; Kirshen AJ; Burd L
    Pediatrics; 1993 Sep; 92(3):420-5. PubMed ID: 8361796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desmopressin has an influence on the arousability of children with primary nocturnal enuresis.
    Eggert P; Fritz A; Stecker B; Müller D
    J Urol; 2004 Jun; 171(6 Pt 2):2586-8; discussion 2588. PubMed ID: 15118425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium fraction excretion rate in nocturnal enuresis correlates with nocturnal polyuria and osmolality.
    Aceto G; Penza R; Delvecchio M; Chiozza ML; Cimador M; Caione P
    J Urol; 2004 Jun; 171(6 Pt 2):2567-70. PubMed ID: 15118420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DDAVP in childhood nocturnal enuresis.
    Tuvemo T
    Acta Paediatr Scand; 1978 Nov; 67(6):753-5. PubMed ID: 568870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is the best treatment for nocturnal enuresis in children?
    Lyon C; Schnall J
    J Fam Pract; 2005 Oct; 54(10):905-6, 909. PubMed ID: 16202382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of DDAVP on nocturnal enuresis in a patient with nephrogenic diabetes insipidus.
    Jonat S; Santer R; Schneppenheim R; Obser T; Eggert P
    Arch Dis Child; 1999 Jul; 81(1):57-9. PubMed ID: 10373137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desmopressin for bed wetting: length of treatment, vasopressin secretion, and response.
    Evans JH; Meadow SR
    Arch Dis Child; 1992 Feb; 67(2):184-8. PubMed ID: 1543376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of a tertiary center enuresis population, with special emphasis on the relation among nocturnal diuresis, functional bladder capacity and desmopressin response.
    Dehoorne JL; Walle CV; Vansintjan P; Raes AM; De Guchtenaere AR; Van Laecke E; Hoebeke P; Vande Walle JG
    J Urol; 2007 Mar; 177(3):1130-7. PubMed ID: 17296432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.